Onconetix, Inc.
ONCO
$0.51
-$0.01-1.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.03% | 185.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.03% | 185.16% | |||
| Cost of Revenue | 60.63% | -3.33% | |||
| Gross Profit | -7.88% | 281.42% | |||
| SG&A Expenses | -35.73% | 53.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -33.20% | 63.89% | |||
| Operating Income | 38.07% | -54.26% | |||
| Income Before Tax | 164.55% | -270.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 164.55% | -270.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 164.55% | -270.25% | |||
| EBIT | 38.07% | -54.26% | |||
| EBITDA | 38.14% | -54.44% | |||
| EPS Basic | 157.84% | 9.56% | |||
| Normalized Basic EPS | 1,024.32% | 83.44% | |||
| EPS Diluted | 157.84% | 9.56% | |||
| Normalized Diluted EPS | 1,024.32% | 83.44% | |||
| Average Basic Shares Outstanding | 11.60% | 150.89% | |||
| Average Diluted Shares Outstanding | 11.60% | 150.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||